{"id":"https://openalex.org/W2144717536","doi":"https://doi.org/10.1093/annonc/mdv300","title":"Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)","display_name":"Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-22","ids":{"openalex":"https://openalex.org/W2144717536","doi":"https://doi.org/10.1093/annonc/mdv300","mag":"2144717536","pmid":"https://pubmed.ncbi.nlm.nih.gov/26202596","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4576908"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdv300","doi":"https://doi.org/10.1093/annonc/mdv300","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdv300","pdf_url":"http://www.annalsofoncology.org/article/S092375341935793X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2144717536"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.annalsofoncology.org/article/S092375341935793X/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080620486","display_name":"Emmanuelle Bompas","orcid":"https://orcid.org/0000-0003-4414-7760","observed_orcids":["https://orcid.org/0000-0003-4414-7760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Bompas","raw_affiliation_strings":["Department of Medical Oncology, Centre Ren\u00e9 Gauducheau, Nantes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre Ren\u00e9 Gauducheau, Nantes","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090103193","display_name":"Axel Le Cesne","orcid":"https://orcid.org/0000-0002-8006-8659","observed_orcids":["https://orcid.org/0000-0002-8006-8659"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Le Cesne","raw_affiliation_strings":["Department of Medical Oncology, Institut Gustave Roussy, Villejuif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Gustave Roussy, Villejuif","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090781649","display_name":"Emmanuelle Tresch\u2010Bruneel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Tresch-Bruneel","raw_affiliation_strings":["Methodology and Biostatistics Unit"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Methodology and Biostatistics Unit","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004551731","display_name":"Lo\u00efc Lebellec","orcid":"https://orcid.org/0000-0002-6079-0185","observed_orcids":["https://orcid.org/0000-0002-6079-0185"]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Lebellec","raw_affiliation_strings":["Department of General Oncology, Centre Oscar Lambret, Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Oncology, Centre Oscar Lambret, Lille","institution_ids":["https://openalex.org/I4210131356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075230685","display_name":"Val\u00e9rie Laurence","orcid":"https://orcid.org/0000-0003-4325-6252","observed_orcids":["https://orcid.org/0000-0003-4325-6252"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V. Laurence","raw_affiliation_strings":["Department of Medical Oncology, Institut Curie, Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Curie, Paris","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019624513","display_name":"Olivier Collard","orcid":"https://orcid.org/0000-0002-8948-4851","observed_orcids":["https://orcid.org/0000-0002-8948-4851"]},"institutions":[{"id":"https://openalex.org/I4210111279","display_name":"Institute Cancer De La Loire Lucien Neuwirth","ror":"https://ror.org/01zss5v68","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111279"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"O. Collard","raw_affiliation_strings":["Department of Medical Oncology, Institut de Canc\u00e9rologie de la Loire, Lucien Neuwirth, Saint Priest en Jarez"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut de Canc\u00e9rologie de la Loire, Lucien Neuwirth, Saint Priest en Jarez","institution_ids":["https://openalex.org/I4210111279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108780490","display_name":"Esma Sa\u00e2da-Bouzid","orcid":"https://orcid.org/0009-0002-3924-286X","observed_orcids":["https://orcid.org/0009-0002-3924-286X"]},"institutions":[{"id":"https://openalex.org/I4210151846","display_name":"Centre Antoine Lacassagne","ror":"https://ror.org/05hmfw828","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210151846"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Saada-Bouzid","raw_affiliation_strings":["Department of Medical Oncology, Centre Antoine Lacassagne, Nice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre Antoine Lacassagne, Nice","institution_ids":["https://openalex.org/I4210151846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082347575","display_name":"Nicol\u00e1s Isambert","orcid":"https://orcid.org/0000-0003-3596-2114","observed_orcids":["https://orcid.org/0000-0003-3596-2114"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N. Isambert","raw_affiliation_strings":["Department of Medical Oncology, Centre GF Leclerc, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre GF Leclerc, Dijon","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042202815","display_name":"Jean\u2010Yves Blay","orcid":"https://orcid.org/0000-0001-7190-120X","observed_orcids":["https://orcid.org/0000-0001-7190-120X"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.Y. Blay","raw_affiliation_strings":["Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022071751","display_name":"Eric Yaovi Amela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E.Y. Amela","raw_affiliation_strings":["Department of General Oncology, Centre Oscar Lambret, Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Oncology, Centre Oscar Lambret, Lille","institution_ids":["https://openalex.org/I4210131356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045172802","display_name":"S\u00e9bastien Salas","orcid":"https://orcid.org/0000-0001-6222-5027","observed_orcids":["https://orcid.org/0000-0001-6222-5027"]},"institutions":[{"id":"https://openalex.org/I4210162909","display_name":"H\u00f4pital de la Timone","ror":"https://ror.org/05jrr4320","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210162909"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Salas","raw_affiliation_strings":["Department of Medical Oncology, Hopital La Timone, Marseille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hopital La Timone, Marseille","institution_ids":["https://openalex.org/I4210162909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103187243","display_name":"Christine Chevreau","orcid":"https://orcid.org/0000-0002-4307-4179","observed_orcids":["https://orcid.org/0000-0002-4307-4179","https://orcid.org/0000-0001-9866-913X"]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Chevreau","raw_affiliation_strings":["Department of Medical Oncology, Institut Claudius Regaud, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Claudius Regaud, Toulouse","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091721810","display_name":"Fran\u00e7ois Bertucci","orcid":"https://orcid.org/0000-0002-0157-0959","observed_orcids":["https://orcid.org/0000-0002-0157-0959"]},"institutions":[{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Bertucci","raw_affiliation_strings":["Department of Medical Oncology, Institut Paoli Calmette, Marseille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Paoli Calmette, Marseille","institution_ids":["https://openalex.org/I4210150365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060949051","display_name":"Anto\u00eene Italiano","orcid":"https://orcid.org/0000-0002-8540-5351","observed_orcids":["https://orcid.org/0000-0002-8540-5351"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Italiano","raw_affiliation_strings":["Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Bergoni\u00e9, Bordeaux","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071477006","display_name":"St\u00e9phanie Clisant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Clisant","raw_affiliation_strings":["Clinical Research Unit, Centre Oscar Lambret, Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Unit, Centre Oscar Lambret, Lille","institution_ids":["https://openalex.org/I4210131356"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052242950","display_name":"Nicolas Penel","orcid":"https://orcid.org/0000-0001-5243-1548","observed_orcids":["https://orcid.org/0000-0001-5243-1548"]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210158359","display_name":"Onco Lille","ror":"https://ror.org/059091v77","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210158359"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"N. Penel","raw_affiliation_strings":["Department of General Oncology, Centre Oscar Lambret, Lille Clinical Research and Methodology Platform, SIRIC OncoLille Consortium, Lille, France n-penel@o-lambret.fr","Clinical Research and Methodology Platform, SIRIC OncoLille Consortium, Lille, France","Department of General Oncology, Centre Oscar Lambret, Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Oncology, Centre Oscar Lambret, Lille Clinical Research and Methodology Platform, SIRIC OncoLille Consortium, Lille, France n-penel@o-lambret.fr","institution_ids":["https://openalex.org/I4210131356","https://openalex.org/I4210158359"]},{"raw_affiliation_string":"Clinical Research and Methodology Platform, SIRIC OncoLille Consortium, Lille, France","institution_ids":["https://openalex.org/I4210158359"]},{"raw_affiliation_string":"Department of General Oncology, Centre Oscar Lambret, Lille","institution_ids":["https://openalex.org/I4210131356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5052242950"],"corresponding_institution_ids":["https://openalex.org/I4210131356","https://openalex.org/I4210158359"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":{"value":5080,"currency":"USD","value_usd":5080},"fwci":10.1616,"has_fulltext":true,"cited_by_count":122,"citation_normalized_percentile":{"value":0.9886109,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"26","issue":"10","first_page":"2168","last_page":"2173"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9760000109672546},{"id":"https://openalex.org/keywords/chordoma","display_name":"chordoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/metastatic-chordoma","display_name":"metastatic chordoma","score":0.9629999995231628},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8339999914169312},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8949999809265137},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9350000023841858},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7630000114440918},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.969679057598114},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9157238006591797},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6678913831710815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6378074884414673},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6018069982528687},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5698886513710022},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5303975343704224},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46618056297302246},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.46120685338974},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.45700016617774963},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4435380697250366},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4328620433807373},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4278603196144104},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.41301608085632324},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0812981128692627}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002817","descriptor_name":"Chordoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002817","descriptor_name":"Chordoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002817","descriptor_name":"Chordoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/annonc/mdv300","doi":"https://doi.org/10.1093/annonc/mdv300","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdv300","pdf_url":"http://www.annalsofoncology.org/article/S092375341935793X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3555282","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4576908","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26202596","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26202596","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:4576908","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4576908/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdv300","doi":"https://doi.org/10.1093/annonc/mdv300","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdv300","pdf_url":"http://www.annalsofoncology.org/article/S092375341935793X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320323807","display_name":"Institut National Du Cancer","ror":"https://ror.org/03m8vkq32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2144717536.pdf","grobid_xml":"https://content.openalex.org/works/W2144717536.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1568316544","https://openalex.org/W1965804113","https://openalex.org/W1988995169","https://openalex.org/W1995614906","https://openalex.org/W2000144646","https://openalex.org/W2021657948","https://openalex.org/W2085703925","https://openalex.org/W2089227214","https://openalex.org/W2094203888","https://openalex.org/W2095572296","https://openalex.org/W2102418043","https://openalex.org/W2112866395","https://openalex.org/W2120155459","https://openalex.org/W2139248078","https://openalex.org/W2140765540","https://openalex.org/W2142170680","https://openalex.org/W2152819546"],"related_works":["https://openalex.org/W2936932625","https://openalex.org/W4379646061","https://openalex.org/W2015003519","https://openalex.org/W7162551062","https://openalex.org/W2611022823","https://openalex.org/W3171775181","https://openalex.org/W7164367099","https://openalex.org/W4399628718","https://openalex.org/W3082053136"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1,72],"is":[2],"no":[3],"consensual":[4],"treatment":[5,167],"of":[6,24,50,118,132,143,168],"locally":[7,169],"advanced":[8,170],"or":[9,171],"metastatic":[10,172],"chordomas.":[11],"PATIENTS":[12],"AND":[13],"METHODS:":[14],"We":[15],"conducted":[16],"a":[17,128,138,166],"multicenter,":[18],"open-label,":[19],"uncontrolled":[20],"phase":[21],"II":[22],"trial":[23],"sorafenib":[25,164],"(800":[26],"mg/day).":[27],"The":[28,64,91],"primary":[29],"end":[30],"point":[31],"was":[32,67,97],"the":[33,48],"9-month":[34,129],"progression-free":[35,130],"rate":[36,131,142],"according":[37],"to":[38,126],"RECIST":[39],"1.1.":[40],"All":[41],"patients":[42,55,80],"had":[43,81],"documented":[44],"progressive":[45],"disease":[46],"at":[47],"time":[49],"study":[51],"entry.":[52],"RESULTS:":[53],"Twenty-seven":[54],"were":[56,73,150],"enrolled":[57],"between":[58],"May":[59],"2011":[60],"and":[61,76,87,104,137,154],"January":[62],"2014.":[63],"median":[65],"age":[66],"64":[68],"(range,":[69],"30-86)":[70],"years.":[71],"17":[74],"men":[75],"10":[77],"women.":[78],"Twelve":[79],"been":[82],"previously":[83],"treated":[84],"with":[85],"chemotherapy":[86],"molecularly":[88],"targeted":[89],"agents.":[90],"maximum":[92],"toxicity":[93],"grade":[94,98,105],"per":[95],"patient":[96],"3":[99],"in":[100,107,152],"21":[101],"cases":[102,109],"(77.8%)":[103],"4":[106,108],"(14.8%).":[110],"Sorafenib":[111],"provided":[112],"an":[113],"intent-to-treat":[114],"best":[115],"objective":[116],"response":[117],"1/27":[119],"[3.7%;":[120],"95%":[121],"confidence":[122],"interval":[123],"(CI)":[124],"0.1%":[125],"19.0%],":[127],"73.0%":[133],"(95%":[134,145],"CI":[135,146],"46.1-88.0)":[136],"12-month":[139],"overall":[140],"survival":[141],"86.5%":[144],"55.8-96.5).":[147],"Survival":[148],"curves":[149],"similar":[151],"pretreated":[153,156],"not":[155],"patients.":[157],"DISCUSSION:":[158],"Additional":[159],"clinical":[160],"trials":[161],"further":[162],"exploring":[163],"as":[165],"chordomas":[173],"are":[174],"warranted.":[175]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2144717536","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
